These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38632681)

  • 21. Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock.
    Guignant C; Voirin N; Venet F; Lepape A; Monneret G
    J Trauma Acute Care Surg; 2012 Jan; 72(1):293-6. PubMed ID: 22310138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.
    Enguix-Armada A; Escobar-Conesa R; García-De La Torre A; De La Torre-Prados MV
    Clin Chem Lab Med; 2016 Jan; 54(1):163-8. PubMed ID: 26083268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin Levels in Survivors and Nonsurvivors of Sepsis: Systematic Review and Meta-Analysis.
    Arora S; Singh P; Singh PM; Trikha A
    Shock; 2015 Mar; 43(3):212-21. PubMed ID: 25423128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.
    Charles PE; Péju E; Dantec A; Bruyère R; Meunier-Beillard N; Dargent A; Prin S; Wilson D; Quenot JP
    Shock; 2017 Oct; 48(4):418-426. PubMed ID: 28414691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
    Spoto S; Basili S; Cangemi R; D'Avanzo G; Lupoi DM; Romiti GF; Argemi J; Yuste JR; Lucena F; Locorriere L; Masini F; Testorio G; Calarco R; Fogolari M; Francesconi M; Battifoglia G; Costantino S; Angeletti S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
    Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
    Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
    Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
    Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating precursor levels of endothelin-1 and adrenomedullin, two endothelium-derived, counteracting substances, in sepsis.
    Schuetz P; Christ-Crain M; Morgenthaler NG; Struck J; Bergmann A; Müller B
    Endothelium; 2007; 14(6):345-51. PubMed ID: 18080871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma midregional proadrenomedullin (MR-proADM) concentrations and their biological determinants in a reference population.
    Krintus M; Kozinski M; Braga F; Kubica J; Sypniewska G; Panteghini M
    Clin Chem Lab Med; 2018 Jun; 56(7):1161-1168. PubMed ID: 29432202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
    Morgenthaler NG; Struck J; Alonso C; Bergmann A
    Clin Chem; 2005 Oct; 51(10):1823-9. PubMed ID: 16099941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.
    Holmager P; Schou M; Egstrup M; Gustafsson I; Goetze JP; Gustafsson F; Klausen TW; Faber J; Kistorp C
    J Card Fail; 2015 Mar; 21(3):250-7. PubMed ID: 25528198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.
    Travaglino F; De Berardinis B; Magrini L; Bongiovanni C; Candelli M; Silveri NG; Legramante J; Galante A; Salerno G; Cardelli P; Di Somma S
    BMC Infect Dis; 2012 Aug; 12():184. PubMed ID: 22874067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
    Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
    Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.
    Önal U; Valenzuela-Sánchez F; Vandana KE; Rello J
    Healthcare (Basel); 2018 Sep; 6(3):. PubMed ID: 30177659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review with meta-analysis of mid-regional pro-adrenomedullin (MR-proadm) as a prognostic marker in Covid-19-hospitalized patients.
    Fialek B; De Roquetaillade C; Pruc M; Navolokina A; Chirico F; Ladny JR; Peacock FW; Szarpak L
    Ann Med; 2023 Dec; 55(1):379-387. PubMed ID: 36607317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.
    Lo Sasso B; Gambino CM; Scichilone N; Giglio RV; Bivona G; Scazzone C; Muratore R; Milano S; Barbagallo M; Agnello L; Ciaccio M
    Lab Med; 2021 Sep; 52(5):493-498. PubMed ID: 33928380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology.
    Bello S; Lasierra AB; Mincholé E; Fandos S; Ruiz MA; Vera E; de Pablo F; Ferrer M; Menendez R; Torres A
    Eur Respir J; 2012 May; 39(5):1144-55. PubMed ID: 22075489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MR-proADM: A New Biomarker for Early Diagnosis of Sepsis in Burned Patients.
    Gille J; Ostermann H; Dragu A; Sablotzki A
    J Burn Care Res; 2017; 38(5):290-298. PubMed ID: 28221298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium.
    Roos M; Schuster T; Ndrepepa G; Baumann M; Lutz J; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
    Heart Vessels; 2012 Jul; 27(4):352-9. PubMed ID: 21725669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.